ESBER HENRY JEMIL
Insider CIK 1391501 · APRI Director · INNV Director · BTHE Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| INNV INNOVUS PHARMACEUTICALS, I | A Award deriv | 2019-07-01 | 2019-07-03 | 5,922 | $1.52 | $9.0K | 34,656 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | A Award deriv | 2019-04-01 | 2019-04-02 | 1,643 | $5.48 | $9.0K | 28,734 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | A Award deriv | 2019-01-02 | 2019-01-04 | 89,552 | $0.07 | $6.3K | 2,842,387 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | A Award deriv | 2018-10-01 | 2018-10-02 | 50,000 | $0.12 | $6.0K | 2,752,835 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | A Award deriv | 2018-07-01 | 2018-07-19 | 54,545 | $0.11 | $6.0K | 2,702,835 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | A Award deriv | 2018-04-01 | 2018-04-03 | 49,059 | $0.12 | $5.9K | 2,648,290 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | A Award deriv | 2018-02-23 | 2018-02-27 | 71,856 | $0.08 | $5.7K | 2,099,231 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | A Award deriv | 2018-02-23 | 2018-02-27 | 500,000 | $0.18 | $90.0K | 2,599,231 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | P Buy | 2017-11-23 | 2017-11-27 | 5,000 | $0.10 | $500 | 100,000 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | P Buy | 2017-11-23 | 2017-11-27 | 90,000 | $0.09 | $8.1K | 90,000 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | P Buy | 2017-11-23 | 2017-11-27 | 5,000 | $0.09 | $450 | 95,000 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | A Award deriv | 2017-10-01 | 2017-10-02 | 65,934 | $0.09 | $5.9K | 2,027,375 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | A Award deriv | 2017-07-01 | 2017-07-03 | 53,286 | $0.11 | $5.9K | 1,961,441 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | A Award deriv | 2017-04-01 | 2017-04-03 | 55,046 | $0.11 | $6.1K | 1,908,155 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | A Award deriv | 2017-01-01 | 2017-01-09 | 30,227 | $0.20 | $6.0K | 1,853,109 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | A Award deriv | 2016-11-16 | 2016-11-21 | 416,667 | $0.25 | $104.2K | 1,215,208 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | A Award deriv | 2016-10-01 | 2016-11-21 | 23,076 | $0.26 | $6.0K | 798,541 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | A Award deriv | 2016-04-01 | 2016-07-15 | 27,650 | $0.21 | $5.8K | 775,465 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | A Award deriv | 2016-04-01 | 2016-07-15 | 89,419 | $0.07 | $6.3K | 747,815 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | A Award deriv | 2016-01-29 | 2016-02-02 | 416,667 | $0.04 | $16.7K | 658,396 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | A Award deriv | 2016-01-04 | 2016-01-06 | 85,714 | $0.07 | $6.0K | 241,729 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | G Gift | 2015-12-30 | 2015-12-31 | 2,949,145 | — | $0 | 0 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | A Award deriv | 2015-10-01 | 2015-10-02 | 63,158 | $0.10 | $6.3K | 156,015 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | A Award deriv | 2015-07-02 | 2015-07-07 | 50,000 | $0.12 | $6.0K | 92,857 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | A Award deriv | 2015-04-01 | 2015-04-03 | 42,857 | $0.14 | $6.0K | 42,857 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | A Award deriv | 2015-03-31 | 2015-04-01 | 500,000 | — | $0 | 500,000 | SEC↗ |
| BTHE Boston Therapeutics, Inc. | P Buy | 2015-03-18 | 2015-03-20 | 9,000 | $0.20 | $1.8K | 13,000 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | A Award | 2015-01-02 | 2015-01-06 | 37,500 | — | $0 | 1,826,284 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | A Award | 2014-10-01 | 2014-10-03 | 16,216 | — | $0 | 1,788,784 | SEC↗ |
| BTHE Boston Therapeutics, Inc. | A Award deriv | 2014-09-25 | 2015-03-20 | 6,000 | — | $0 | 228,000 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | A Award | 2014-07-01 | 2014-07-03 | 22,222 | — | $0 | 1,772,568 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | A Award | 2014-04-01 | 2014-04-02 | 14,634 | — | $0 | 1,750,346 | SEC↗ |
| BTHE Boston Therapeutics, Inc. | A Award deriv | 2014-03-13 | 2014-04-21 | 100,000 | — | $0 | 222,000 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-20 | 190,304 | — | $0 | 1,735,712 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-20 | 37,964 | — | $0 | 1,545,408 | SEC↗ |
| BTHE Boston Therapeutics, Inc. | A Award deriv | 2014-02-12 | 2014-04-21 | 77,000 | — | $0 | 122,000 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | A Award | 2014-02-04 | 2014-02-06 | 15,000 | — | $0 | 1,507,444 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | A Award | 2013-10-16 | 2013-10-18 | 3,750 | — | $0 | 1,492,444 | SEC↗ |
| BTHE Boston Therapeutics, Inc. | A Award deriv | 2013-01-01 | 2014-04-21 | 25,000 | — | $0 | 45,000 | SEC↗ |
| BTHE Boston Therapeutics, Inc. | A Award deriv | 2012-11-08 | 2014-04-21 | 20,000 | — | $0 | 20,000 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | A Award deriv | 2012-01-03 | 2012-01-04 | 16,000 | — | $0 | 16,000 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | A Award | 2012-01-03 | 2012-01-04 | 2,505 | $5.13 | $12.9K | 609,217 | SEC↗ |